Biotechnology

Techseriesinsight > Blog > News > Biotechnology

July 22, 2026
PRNewswire
Biotechnology, News

DEMETRA ANNOUNCES A STRATEGIC COLLABORATION WITH MASMEC BIOMED

Demetra Holding announces a strategic collaboration with Masmec Biomed, an Italian company specialized in the development of advanced surgical navigation systems, AI, and high-complexity medical technologies. The collaboration stems...

July 22, 2026
Business Wire
Biotechnology, News

Signatera™ MRD Outperformed AMERK Testing in Predicting Merkel Cell Carcinoma Recurrence in JAMA Dermatology Study

Natera, Inc, a global leader in cell-free DNA and precision medicine, today announced the publication of results from a prospective, multicenter study in Merkel cell carcinoma (MCC) published in JAMA Dermatology. The...

July 21, 2026
PRNewswire
Biotechnology, News

Ebix Appoints Mary Beth Titsworth as Vice President for its Health and Wellness Vertical

Ebix today announced the appointment of Mary Beth Titsworth as Vice President, Health Content, for its Health and Wellness vertical. In this role, Titsworth will lead the growth strategy...

July 20, 2026
PRNewswire
Biotechnology, News

IntelliGenome Appoints ILEX South Africa as Exclusive Distributor for CRISPR-TB

IntelliGenome, Inc., a biotechnology company developing CRISPR-based molecular diagnostics, today announced the appointment of ILEX South Africa (Pty) Ltd. as its exclusive distributor for CRISPR-TB® in South Africa. South Africa...

July 17, 2026
Business Wire
Biotechnology, News

ME Therapeutics Closes Over-Subscribed Private Placement

ME Therapeutics Holdings Inc. (“ME Therapeutics” or the “Company”), a publicly listed biotechnology company working on novel cancer fighting drugs that reprogram and redirect immune cells to fight cancer,...

July 16, 2026
PRNewswire
Biotechnology, News

Synapticure Launches Groundbreaking Ataxia Care Program, Expanding Access to Specialized Neurology Nationwide

Synapticure, a leading virtual care company dedicated to improving access and outcomes for patients and caregivers living with neurodegenerative diseases, today announced the launch of a virtual ataxia care...

July 14, 2026
PRNewswire
Biotechnology, News

HitGen Partner BioAge Labs Doses First Participant in Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor for Cardiovascular Risk Reduction

A clinical-stage biopharmaceutical company developing therapeutic product candidates for cardiometabolic diseases by targeting the biology of human aging, on dosing the first participant in QUELL-CV, a Phase 2 proof-of-concept...

July 10, 2026
PRNewswire
Biotechnology, News

TheWell Bioscience Launches RocketCell™ Cell Viability Enhancer to Improve Cell Recovery, Survival, and Expansion Following Passaging, Cryopreservation, and Organoid Harvesting

TheWell Bioscience, a leader in xeno-free 3D cell culture technologies, today announced the launch of RocketCell™ Cell Viability Enhancer (1000X), a next-generation cell recovery reagent engineered to maximize cell...

July 9, 2026
Business Wire
Biotechnology, News

ClearNote Health Announces Leadership Transition

A company dedicated to improving early detection for some of the deadliest cancers, today announced a leadership transition. Kevin Keegan, currently president and chief operating officer, has been appointed...

July 8, 2026
PRNewswire
Biotechnology, News

UCB Awards Annual Myasthenia Gravis Scholarships to 15 Individuals Impacted by MG in the U.S.

UCB, a global biopharmaceutical company, today announced the recipients of its annual UCB Myasthenia Gravis Scholarship,™ awarding 15 scholarships to individuals in the United States who are living with...